Findings

What do systematic reviews say?

7 questions · 11 findings · 1 reviews · Developmental, Psychosocial and Learning Problems

No studies found 4 · 36.4%GRADE not reported 0 · 0%Very low 2 · 18.2%Low 5 · 45.5%Moderate 0 · 0%High 0 · 0%

Dexamphetamine · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

The review found no eligible studies for this question.

1 finding from 1 review

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

All amphetamines · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

The review found no eligible studies for this question.

1 finding from 1 review

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Retention in treatment · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

Amphetamines showed no clear difference in retention in treatment compared with placebo (low certainty).

1 finding from 1 review

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes only
RR 1.06 [0.99, 1.13]
17 studies · 2323 participants
Low

ADHD symptom severity: clinician rated · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

3 findings from 1 review

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Very low
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 896 participants
Low
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 1083 participants
Low

ADHD symptom severity: patient rated · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

3 findings from 1 review

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 35 participants
Low
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 67 participants
Low
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 18 participants
Very low

Lisdexamfetamine · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

The review found no eligible studies for this question.

1 finding from 1 review

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mixed amphetamine salts · adults with ADHD (available evidence for participants aged between 25 to 53 years old)

The review found no eligible studies for this question.

1 finding from 1 review

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found